Replimune is at the forefront of cancer treatment, developing pioneering oncolytic immunotherapies that leverage a proprietary HSV-1 platform to activate robust anti-tumor responses. Tailored for difficult-to-treat cancers, our treatments aim to transform the landscape of oncological care by delivering both local and systemic tumor-killing effects, while enhancing the effectiveness of existing therapies.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching
Want job alerts that match your preferences?
Set up job preferences →